Literature DB >> 9825850

The response of adenomyosis to endometrial ablation/resection.

V McCausland1, A McCausland.   

Abstract

Operative hysteroscopy is a relatively new technique that has significantly improved the diagnosis and therapy of abnormal uterine bleeding. At first, the success of operative hysteroscopy in controlling this bleeding seemed extremely high but, with long-term follow-up, a significant failure rate became evident requiring a repeat hysteroscopic procedure or a hysterectomy. Deep adenomyosis is a major cause of these failures. This paper describes three operative ablation techniques and relates many of their failures to deep adenomyosis. The definition and pathophysiology of adenomyosis are also explored. The possibility of delaying the diagnosis of endometrial cancer under an ablation scar is discussed. Ultimately the depth of adenomyosis seems to correlate with the outcome of endometrial ablation or resection. Patients without or with only minimal endometrial penetration of <2.5 mm (superficial adenomyosis) have good results from the ablation. Patients with deep endometrial penetration of >2.5 mm (deep adenomyosis) usually have persistent problems and should be offered hysterectomy over repeat ablation. Magnetic resonance imaging or ultrasound may be an appropriate pre-operative screening tool to determine the depth of ademomyosis.

Entities:  

Mesh:

Year:  1998        PMID: 9825850     DOI: 10.1093/humupd/4.4.350

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  9 in total

Review 1.  Adenomyosis - An Overview.

Authors:  Stephanie Wong; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2022-02-18       Impact factor: 1.513

2.  Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach.

Authors:  Ha Ryun Won; Jason Abbott
Journal:  Int J Womens Health       Date:  2010-08-20

3.  Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis.

Authors:  Rui Zheng; Dan Zeng; Ting-Ting Wan; Wen-Bo Guo; Yan Guo; Ming-Juan Liu
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

4.  [The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis].

Authors:  Junyao Lou; Xiufeng Huang; Lifeng Zhang; Ping Xu; Xinmei Zhang; Zhengyun Chen
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-25

5.  Predictive value of magnetic resonance imaging in differentiating between leiomyoma and adenomyosis.

Authors:  Rosa Moghadam; Ruth B Lathi; Babac Shahmohamady; Naghmeh S Saberi; Ceana H Nezhat; Farr Nezhat; Camran Nezhat
Journal:  JSLS       Date:  2006 Apr-Jun       Impact factor: 2.172

Review 6.  The Role of Hysteroscopy in the Diagnosis and Treatment of Adenomyosis.

Authors:  Attilio Di Spiezio Sardo; Gloria Calagna; Fabrizia Santangelo; Brunella Zizolfi; Vasilis Tanos; Antonino Perino; Rudy Leon De Wilde
Journal:  Biomed Res Int       Date:  2017-08-09       Impact factor: 3.411

Review 7.  The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility.

Authors:  Jin-Jiao Li; Jacqueline P W Chung; Sha Wang; Tin-Chiu Li; Hua Duan
Journal:  Biomed Res Int       Date:  2018-03-15       Impact factor: 3.411

8.  The effect of transcervical endometrial resection on clinical symptoms related to intrinsic adenomyosis and junctional zone changes.

Authors:  Christina K Rasmussen; Estrid S Hansen; Sham Al-Mashadi Dahl; Erik Ernst; Margit Dueholm
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-04-30

9.  Laparoscopic Radiofrequency Thermal Ablation for Uterine Adenomyosis.

Authors:  Stefano Scarperi; Giovanni Pontrelli; Colette Campana; Martin Steinkasserer; Alfredo Ercoli; Luca Minelli; Valentino Bergamini; Marcello Ceccaroni
Journal:  JSLS       Date:  2015 Sep-Dec       Impact factor: 2.172

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.